US-China AI Rivalry Grows With Alibaba's Anthropic Rival
THE SO WHAT
Chinese labs claiming Anthropic-level performance underscores that the US–China AI gap is narrowing in practice, even if benchmarks still show a lag. Multinationals need a dual-stack strategy — one eye on export controls and one on where Chinese models may be cheaper or better-tuned for local markets.
READ THE SOURCE
MORE FROM THE WIRE
Applied AIDisrupting a Criminal Scam Operation
AI-native fraud is now organized enough that labs are running counter-intel ops against specific scam shops. If your product touches payments, dating, or gambling, assume you’re already in an arms race with LLM-augmented fraud rings and budget for continuous abuse tooling, not one-off rules.
Applied AIEurope starts enforcing AI Act rules
AI Act enforcement moves compliance from slideware to line item — model transparency, data provenance, and risk documentation now have real cost and timeline impact in Europe. If you ship or buy AI in the EU, treat this week as the starting gun for vendor audits, model classification, and contract rewrites around liability.
Applied AIThe billion-dollar question: How will the neolabs actually make money?
The fact that ‘how do the neolabs monetize?’ is still an open question tells you model quality alone isn’t the business model — distribution, integration, and control of workloads are. As an operator, assume foundation models commoditize over time and design your strategy around data, workflow depth, and where you sit in the value chain, not around a single lab relationship.
Applied AIBenchmark Firm: China AI Models Still Lag US Rivals
A 3–9 month lag for leading Chinese models versus US peers is close enough that policy, data access, and deployment scale — not raw capability — become the differentiators. If you operate in or with China, assume near-parity for many workloads and plan governance and procurement as if a credible domestic alternative exists.